J Rheumatol:银屑病关节炎的经济负担评估及其功能状态与医疗费用的关系

2020-01-19 xiangting MedSci原创

PsA患者给医疗系统带来了巨大的经济负担。功能状态与费用高度相关,并且主要是由二级保健咨询的费用引起的。

该分析旨在评估英国医疗系统中银屑病关节炎(PsA)患者的经济负担,并估计功能状态与直接医疗费用的关系。

功能状态[使用健康评估问卷-残疾指数(HAQ-DI)进行测量]、人口学、疾病史和医疗资源使用数据来自英国巴斯皇家国立风湿病医院的一组患者。然后为每位患者分配每个资源使用项目的单位成本。使用线性回归模型预测作为HAQ-DI函数的成本。初步分析不包括药费,药费从英国国家卫生服务局的角度进行计算。

101名患者的数据。HAQ-DI的平均得分为0.84SD 0.75),HAQ-DI测量时的平均年龄为57.8岁(SD 10.7)。每名患者每年的总医疗成本(不包括药费)在174英镑至8885英镑之间,平均为1586英镑(SD 1639英镑)。HAQ-DI评分每增加1分,总费用就会增加547.49英镑(标准误为224英镑),而二级保健咨询似乎是主要因素。亚组分析表明,HAQ-DI评分2-3且病程>10年的患者费用增加较多。

PsA患者给医疗系统带来了巨大的经济负担。功能状态与费用高度相关,并且主要是由二级保健咨询的费用引起的。结果与以前在类风湿性关节炎人群中进行的研究相似。

原始出处:

Neil McHugh. Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare Costs. J Rheumatol. January 2020.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1266102, encodeId=c1311266102c5, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457942, encodeId=d8c8145e942cf, content=<a href='/topic/show?id=e604351e60d' target=_blank style='color:#2F92EE;'>#医疗费用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35176, encryptionId=e604351e60d, topicName=医疗费用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16bd5999183, createdName=wangyang7960, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487743, encodeId=5d81148e74338, content=<a href='/topic/show?id=6a40e83665a' target=_blank style='color:#2F92EE;'>#经济负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78366, encryptionId=6a40e83665a, topicName=经济负担)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3e8357293, createdName=bioon6, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622932, encodeId=f6501622932f7, content=<a href='/topic/show?id=abff3292584' target=_blank style='color:#2F92EE;'>#功能状态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32925, encryptionId=abff3292584, topicName=功能状态)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=)]
    2020-01-21 lmm397
  2. [GetPortalCommentsPageByObjectIdResponse(id=1266102, encodeId=c1311266102c5, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457942, encodeId=d8c8145e942cf, content=<a href='/topic/show?id=e604351e60d' target=_blank style='color:#2F92EE;'>#医疗费用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35176, encryptionId=e604351e60d, topicName=医疗费用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16bd5999183, createdName=wangyang7960, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487743, encodeId=5d81148e74338, content=<a href='/topic/show?id=6a40e83665a' target=_blank style='color:#2F92EE;'>#经济负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78366, encryptionId=6a40e83665a, topicName=经济负担)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3e8357293, createdName=bioon6, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622932, encodeId=f6501622932f7, content=<a href='/topic/show?id=abff3292584' target=_blank style='color:#2F92EE;'>#功能状态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32925, encryptionId=abff3292584, topicName=功能状态)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1266102, encodeId=c1311266102c5, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457942, encodeId=d8c8145e942cf, content=<a href='/topic/show?id=e604351e60d' target=_blank style='color:#2F92EE;'>#医疗费用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35176, encryptionId=e604351e60d, topicName=医疗费用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16bd5999183, createdName=wangyang7960, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487743, encodeId=5d81148e74338, content=<a href='/topic/show?id=6a40e83665a' target=_blank style='color:#2F92EE;'>#经济负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78366, encryptionId=6a40e83665a, topicName=经济负担)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3e8357293, createdName=bioon6, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622932, encodeId=f6501622932f7, content=<a href='/topic/show?id=abff3292584' target=_blank style='color:#2F92EE;'>#功能状态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32925, encryptionId=abff3292584, topicName=功能状态)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1266102, encodeId=c1311266102c5, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457942, encodeId=d8c8145e942cf, content=<a href='/topic/show?id=e604351e60d' target=_blank style='color:#2F92EE;'>#医疗费用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35176, encryptionId=e604351e60d, topicName=医疗费用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16bd5999183, createdName=wangyang7960, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487743, encodeId=5d81148e74338, content=<a href='/topic/show?id=6a40e83665a' target=_blank style='color:#2F92EE;'>#经济负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78366, encryptionId=6a40e83665a, topicName=经济负担)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3e8357293, createdName=bioon6, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622932, encodeId=f6501622932f7, content=<a href='/topic/show?id=abff3292584' target=_blank style='color:#2F92EE;'>#功能状态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32925, encryptionId=abff3292584, topicName=功能状态)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jan 21 09:17:00 CST 2020, time=2020-01-21, status=1, ipAttribution=)]

相关资讯

J Rheumatol:银屑病关节炎神经性疼痛的特征

神经性疼痛特征在PsA患者中很常见,并且存在疼痛敏化(合并FMS)是其主要预测因子。

J Rheumatol:银屑病关节炎患者药理生物标志物与治疗反应和长期残疾的关联

检测ADA初治PsA患者的药物水平有助于确定12个月内的治疗反应/残疾。

J Rheumatol:生物制剂治疗银屑病关节炎的指炎和附着点炎

汇总分析表明,抗TNF-α制剂对指炎和附着点炎的疗效与新型药物相同(乌司奴单抗、苏金单抗、依克珠单抗)。

Ann Rheum Dis:银屑病或银屑病关节炎使用生物制剂出现严重感染的相对风险

与TNF和IL-17抑制剂相比,IL-12/23抑制剂与生物制剂初治的PsO或PsA患者严重感染的风险降低相关。

银屑病关节炎头对头实验中,诺华的IL-17单抗Cosentyx与Humira相比未能实现统计学意义的改善

在银屑病关节炎(PsA)的头对头试验中,诺华的白细胞介素-17单抗Cosentyx(secukinumab)未能显示出超过AbbVie的Humira(adalimumab)的显着优势。尽管Cosentyx与Humira相比显示出更高的结果,但勉强错过了EXCEED试验主要终点,即ACR 20具有统计学意义的优越性。

J Rheumatol:中轴型银屑病关节炎和影像学骶髂关节炎中的当前吸烟者增多

在PsA患者中,当前吸烟与axPsA和影像学骶髂关节炎均显著相关。